BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Avanceña ALV, Miller N, Uttal SE, Hutton DW, Mellinger JL. Cost-effectiveness of alcohol use treatments in patients with alcohol-related cirrhosis. J Hepatol 2021;74:1286-94. [PMID: 33326815 DOI: 10.1016/j.jhep.2020.12.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Haque LY, Fiellin DA. Bridging the Gap: Dual Fellowship Training in Addiction Medicine and Digestive Diseases. Dig Dis Sci. [DOI: 10.1007/s10620-022-07478-9] [Reference Citation Analysis]
2 Murthy P, Shadakshari D, Mahadevan J, Chand PK. Management of Alcohol Use Disorder in Patients with Alcoholic Liver Disease. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.04.010] [Reference Citation Analysis]
3 Nielsen AS, Askgaard G, Thiele M. Treatment of alcohol use disorder in patients with liver disease. Curr Opin Pharmacol 2022;62:145-51. [PMID: 34999372 DOI: 10.1016/j.coph.2021.11.012] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Li M, Qu Y, Zhong J, Che Z, Wang H, Xiao J, Wang F, Xiao J. Sex bias in alcohol research: A 20-year comparative study. Front Neuroendocrinol 2021;63:100939. [PMID: 34411573 DOI: 10.1016/j.yfrne.2021.100939] [Reference Citation Analysis]
5 Kichloo A, El-Amir Z, Dahiya DS, Wani F, Singh J, Solanki D, Edigin E, Eseaton P, Mehboob A, Shaka H. Trends of alcoholic liver cirrhosis readmissions from 2010 to 2018: Rates and healthcare burden associated with readmissions. World J Hepatol 2021; 13(12): 2128-2136 [DOI: 10.4254/wjh.v13.i12.2128] [Reference Citation Analysis]
6 German MN, Brown R, Lucey MR. Out With the Old, in With the New: Replacing the "6-Month Abstinence Rule" With Integrated Care for Alcohol-Associated Liver Disease. Gastroenterology 2021;161:1795-7. [PMID: 34563475 DOI: 10.1053/j.gastro.2021.09.041] [Reference Citation Analysis]